Australian scientists have discovered that regular fish oil has the potential to break down superbugs' ability to become resistant to antibiotics.
PanKind has launched the PanKind Early Detection Initiative in a move to strategically work with the research community to improve early diagnosis of pancreatic cancer.
World Allergy Week is seeking to raise awareness of allergies and anaphylaxis, with leading allergy organisations promoting important resources that could save lives.
Novavax's COVID-19 vaccine demonstrated 100% protection against moderate and severe disease, with 90.4% efficacy overall, in the PREVENT-19 Phase 3 trial.
The Hip Fracture Registry Toolbox is a practical and informative resource that explains the need, and how to best advocate, for the establishment of a national hip fracture registry.
GSK Australia has announced that a new vaccine to help protect against shingles in adults aged 50 years and older is now available on the private market in Australia.
The mobile medical clinic providing health care to the homeless community in NSW is calling on doctors, nurses, physios and other medical volunteers.
National clinical practice guidelines to diagnose and treat endometriosis have been released, aiming to improve the lives of women living with the debilitating condition.
Sydney-based medical device start-up RRR has secured European regulatory approval for its personal automated external defibrillator (AED), CellAED.
A vaginal progesterone pessary is reported to be the first progesterone treatment to be reimbursed via the PBS for the prevention of preterm birth.
Reduced levels of the metabolic hormone leptin may be responsible for poor vaccine efficacy among certain individuals, according to a new study.
The smartphone-based pain assessment application has potential for use in children's hospitals, in postnatal wards, and among parents and other healthcare professionals.
Early research suggests that climate change could lead to more stillbirths.
This fortnight is the last chance for aged-care facilities to participate in the government-subsidised rollout of a complete point-of-care solution for best practice pain management.
The Avalon Study has demonstrated the life-changing benefits of a closed-loop spinal cord stimulation system in patients with chronic, intractable pain.